Beone Medicines Ltd. Class A — BeiGene — Fact Sheet (February 2024)

3 slides from Beone Medicines Ltd. Class A's fact sheet, February 2024

Slide 1: GZ Manufacturing Campus
GZ Manufacturing Campus Feb 2024 BeiGene Confidential
Slide 2: First Biologics Manufacturing Facility
First Biologics Manufacturing Facility North Campus: Clinical & Commercial Biologics production (New) South Campus: Clinical & Commercial ADC production Drug • DS Suite 1-3 with Single-use 2kL and Stainless 5kL + ADC Conjugation Room with 250L Stainless-Steel Tank • Batch and Fed-batch • Partnership
Slide 3: BeiGene Global Manufacturing Capabilities Overview
BeiGene Global Manufacturing Capabilities Overview Guangzhou, China Site | Clinical & Commercial Biologics production • DS Suite 4 with Single-use 500L, 2kL and Stainless 5kL Global Quality Drug • Batch and Fed-batch Track Record Substance • Mammalian (mAb, BsAb/TsAb, Fabs, Fusion, Recombinant prote